Without added losartan, anti-PD-1 treatment resulted in the expected increase in Teff cells, but the reinvigorated CD8+ T cells mainly remained at the tumor margin with very few of them detected within the tumor proper. The gene discussed is CD8A; the disease is neoplasm.